Research Options: Select below IPO Calendar	Week of Expected Pricing Pending Company Name Tvax Biomedical, Inc. Proposed Ticker TVAX CUSIP 87306M109 Business Description A biotechnology company focused on the development of targeted cell-based immunotherapies for the treatment of cancer. Lead Underwriter Roth Capital Partners, Inc Co-Managers Cantor Fitzgerald/ Aegis Capital Initial Shares 2000000 Revised Initial Shares N/A Initial Price $9.00-$11.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.